Trial Profile
A Phase I/II Trial of Pomalidomide and Dexamethasone in Subjects With Previously-Treated AL Amyloidosis
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Pomalidomide (Primary) ; Dexamethasone
- Indications Amyloid light-chain amyloidosis
- Focus Adverse reactions
- 03 Sep 2020 Status changed from active, no longer recruiting to completed.
- 24 Apr 2018 Planned primary completion date changed from 1 May 2018 to 1 Dec 2018.
- 30 Oct 2017 Planned primary completion date changed from 1 Oct 2017 to 1 May 2018.